Moonshots EP 178: Harvard Prof Reveals Age-Reversing Science to Look and Feel Younger

Summary

A deep one-on-one between Peter Diamandis and Dr. David Sinclair (Harvard Medical School professor, author of Lifespan) providing a state-of-the-union on age reversal science. Sinclair’s core thesis is the Information Theory of Aging (ITA): aging is not wear-and-tear but loss of epigenomic information, like software corruption. The genome stays stable, but the epigenome — which genes are bundled (silenced) vs. open (active) — degrades over time due to DNA breaks and cellular stress. The breakthrough: his lab proved in a 2020 Nature paper that you can reverse aging by activating Yamanaka genes normally only expressed in embryos, resetting cells’ epigenomic state using a “backup copy” (the “observer” in Claude Shannon’s information theory framework). In green monkeys, optic nerve age was reversed by ~95%, and the treatment is semi-permanent — turn genes on for 6-8 weeks, then off; eyes stay young until aging recurs, then repeat. Life Biosciences is entering human clinical trials in January 2026 for glaucoma and eye stroke (NAION). Beyond gene therapy ($300-400K per treatment), Sinclair’s lab has used AI to discover oral small molecules that cost ~$100/month and reversed aging physiology in mice within 4 weeks of Monday/Wednesday/Friday dosing. His 2035 vision: a pill taken for 4 weeks that makes you measurably younger, at pennies per dose. He believes teenagers today will live into the 22nd century and stands by his prediction that the first person to live to 150 has already been born. The episode also covers the $101M Healthspan XPRIZE (625 teams, $157M raised, Sinclair’s lab registered), sequential cloning experiments proving mutations don’t drive aging (23 sequential mouse clones stayed healthy), and the crypto community emerging as a major longevity funder (Bezos/Milner backing Altos, Armstrong backing NewLimit, Altman backing Retro).

Key Segments

• [00:00-08:00] 2035 vision, information theory of aging overview, Life Biosciences human trials January 2026, AI-discovered oral molecules at $100/month
• [08:00-18:00] Gene therapy on/off system, 95% optic nerve age reversal in monkeys, longevity escape velocity timeline
• [18:00-28:00] Why we age (epigenomic information loss, not mutations), Claude Shannon’s observer framework, skin/hair organoid experiments
• [28:00-35:00] $101M Healthspan XPRIZE, academic funding crisis for longevity research, crypto community as longevity funders

Notable Claims

• Optic nerve age reversed ~95% in green monkeys using Yamanaka gene therapy; treatment is repeatable with on/off switch
• AI-discovered oral molecules reversed mouse aging physiology in 4 weeks at ~$100/month cost; goal is pennies per dose
• 23 sequential mouse clones stayed healthy — proving mutations don’t drive aging, the epigenome does
• Life Biosciences entering human clinical trials January 2026 for glaucoma and eye stroke
• Sinclair predicts teenagers today will live into the 22nd century; first person to live to 150 has already been born
• Dario Amodie (Anthropic CEO) at Davos: expects doubling of human lifespan within 10 years
• Demis Hassabis (DeepMind CEO) on 60 Minutes: foresees end of all disease by end of the decade